Researchers raise bar for successful management of severe atopic dermatitis

January 15, 2019

AURORA, Colo. (Jan. 15, 2019) - A team of investigators from the University of Colorado College of Nursing at CU Anschutz Medical Campus and National Jewish Health has identified comprehensive guidelines for managing severe atopic dermatitis (AD), the most common form of eczema.

The clinical management review was recently published in The Journal of Allergy and Clinical Immunology: In Practice.

"The FDA approval of biologic medication for treating moderate-to-severe AD has transformed the therapeutic landscape highlighting the need for comprehensive and clear guidelines," said Noreen Nicol, PhD, RN, Associate Professor in the College of Nursing at CU Anschutz Medical Campus. "Without comprehensive guidelines that analyze national and international findings, we risk clinicians skipping crucial conventional steps, such as wet-wrap therapy, that need to be utilized prior to initiating biologics."

Atopic dermatitis affects up to 18 percent of children as well as seven percent of adults. As a chronic, relapsing disease, severe AD has a profound impact on the quality of life of patients and families. Recent studies reveal patients with severe cases report high itch frequency of up to 18 hours a day, sleep disturbance and borderline or abnormal quality of life scores.

Current guidelines for decision making about advancement to systemic therapy in severe AD are misunderstood or not used. Treatment has often been reactive with inappropriate use of systemic corticosteroids and unapproved systemic immunosuppressants - drugs that suppress, or reduce, the strength of the body's immune response. Additionally, international guidelines for treatment differ widely among countries.

In their clinical review, the researchers incorporate national and international guidelines to deliver a comprehensive algorithm to guide clinicians in treating AD patients, as seen in the chart.

The steps include: "Life with severe atopic dermatitis can be incredibly difficult for our patients and their families, and it can be quite challenging to care for. It's important to let our patients, caregivers, and healthcare providers know that we have entered a new and exciting era in the treatment of AD with a number of targeted therapies approved or being studied which are referenced in this clinical review," said Mark Boguniewicz, MD, Professor, Division of Allergy-Immunology and Department of Pediatrics at National Jewish Health and University of Colorado School of Medicine.
-end-
About the University of Colorado Anschutz Medical Campus

The University of Colorado Anschutz Medical Campus is a world-class medical destination at the forefront of life-changing science, medicine, and healthcare. CU Anschutz serves over 4,500 students and offers more than 40 degree programs through six schools and colleges. We are the single largest health professions education provider in Colorado, awarding over 1,400 degrees annually and home to Children's Hospital Colorado and UCHealth University of Colorado Hospital. Powered by our award-winning faculty, renowned researchers and a reputation for academic excellence, and with over $500 million in research awards in 2018, the CU Anschutz Medical Campus drives innovation from the classroom to the laboratory to the delivery of unparalleled patient care.

University of Colorado Anschutz Medical Campus

Related Nursing Articles from Brightsurf:

Dismantling structural racism in nursing
Confronting the uncomfortable reality of systemic racism - the system that creates and maintains racial inequality in every facet of life for people of color - is having a national heyday.

MU School of Nursing programs help nursing homes respond to COVID-19
As the coronavirus pandemic continues to put a strain on health care systems, nursing homes have become overburdened with the challenge of keeping both patients and staff safe and healthy.

Palliative nursing's role during COVID-19 and beyond
As a rapid influx of patients overwhelmed health systems during the coronavirus pandemic, palliative nurses played dual roles supporting patients, patient families, and colleagues.

Calling for nursing support amid COVID-19 pandemic
There are close to 28 million nurses around the world who comprise a global workforce that delivers about 90 percent of primary healthcare, including frontline response to the COVID-19 pandemic.

Nursing research informs response to COVID-19 pandemic
Nursing research has an important influence on evidence-based health care practice, care delivery, and policy.

Designing better nursing care with robots
Robots are becoming an increasingly important part of human care, according to researchers based in Japan.

A work patch for better nursing home care
A research team, including a Purdue University work-life balance expert, studied work schedules in nursing home facilities and found a patching approach could benefit patients and staff.

Nursing science could help reduce firearm violence and its impact
Firearm violence is a significant public health problem worldwide. In the United States, firearms are used to kill almost 100 people daily.

A nursing perspective on the opioid crisis
Addictions nursing specialists have a unique role to play in caring for patients, families, and communities affected by the crisis.

Nursing notes can help indicate whether ICU patients will survive
Researchers at the University of Waterloo have found that sentiments in the nursing notes of health care providers are good indicators of whether intensive care unit (ICU) patients will survive.

Read More: Nursing News and Nursing Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.